Keywords: اسکلرومیکسدام; G-CSF; Granulocyte-colony stimulating factor; GvD; Graft versus disease; GVHD; Graft-versus-host disease; HLA; Human leukocyte antigen; IgG kappa; Immunoglobulin G kappa; MRI; Magnetic resonance imaging; SCT; Stem cell transplantation; SM; Scleromyxedema;